| Columbus Physicians Associates Pc | |
|
2753 Foxpointe Drive Columbus IN 47203-3224 | |
| (812) 376-7824 | |
| (812) 378-8390 |
| Full Name | Columbus Physicians Associates Pc |
|---|---|
| Speciality | Family Medicine |
| Location | 2753 Foxpointe Drive, Columbus, Indiana |
| Authorized Official Name and Position | Theodora Saddoris (PRESIDENT) |
| Authorized Official Contact | 8123767824 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Columbus Physicians Associates Pc 2753 Foxpointe Drive Columbus IN 47203-3224 Ph: (812) 376-7824 | Columbus Physicians Associates Pc 2753 Foxpointe Drive Columbus IN 47203-3224 Ph: (812) 376-7824 |
| NPI Number | 1346290566 |
|---|---|
| Provider Enumeration Date | 05/10/2006 |
| Last Update Date | 04/05/2021 |
| Medicare PECOS PAC ID | 6103987508 |
|---|---|
| Medicare Enrollment ID | O20081203000758 |
News Archive
Vagus nerve stimulation (VNS) therapy, a treatment recently approved by the Food and Drug Administration for treatment-resistant depression, produced a positive response in more than 25 percent of patients in a national, yearlong study led by UT Southwestern Medical Center psychiatrists
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
What happens when doctors cannot cure a disease? What is the best way to make patients comfortable and have the best quality of life possible in the time they have left? Researchers at the Norwegian University of Science and Technology (NTNU) have developed software that can be used with an iPad or other tablet to help record patient pain levels to help doctors in developing further treatment.
Air pollution has already been linked to a range of health problems. Now, a ground-breaking new study suggests pollution from traffic may put women at risk for another deadly disease.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346290566 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| 207R00000X | Internal Medicine | (* (Not Available)) | Secondary |
| Provider Name | Theodora Saddoris |
|---|---|
| Provider Type | Practitioner - Addiction Medicine |
| Provider Identifiers | NPI Number: 1245280536 PECOS PAC ID: 8820159213 Enrollment ID: I20081203000750 |
News Archive
Vagus nerve stimulation (VNS) therapy, a treatment recently approved by the Food and Drug Administration for treatment-resistant depression, produced a positive response in more than 25 percent of patients in a national, yearlong study led by UT Southwestern Medical Center psychiatrists
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
What happens when doctors cannot cure a disease? What is the best way to make patients comfortable and have the best quality of life possible in the time they have left? Researchers at the Norwegian University of Science and Technology (NTNU) have developed software that can be used with an iPad or other tablet to help record patient pain levels to help doctors in developing further treatment.
Air pollution has already been linked to a range of health problems. Now, a ground-breaking new study suggests pollution from traffic may put women at risk for another deadly disease.
› Verified 3 days ago
| Provider Name | John L Nieters |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1093766107 PECOS PAC ID: 1052440922 Enrollment ID: I20100602000790 |
News Archive
Vagus nerve stimulation (VNS) therapy, a treatment recently approved by the Food and Drug Administration for treatment-resistant depression, produced a positive response in more than 25 percent of patients in a national, yearlong study led by UT Southwestern Medical Center psychiatrists
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
What happens when doctors cannot cure a disease? What is the best way to make patients comfortable and have the best quality of life possible in the time they have left? Researchers at the Norwegian University of Science and Technology (NTNU) have developed software that can be used with an iPad or other tablet to help record patient pain levels to help doctors in developing further treatment.
Air pollution has already been linked to a range of health problems. Now, a ground-breaking new study suggests pollution from traffic may put women at risk for another deadly disease.
› Verified 3 days ago
News Archive
Vagus nerve stimulation (VNS) therapy, a treatment recently approved by the Food and Drug Administration for treatment-resistant depression, produced a positive response in more than 25 percent of patients in a national, yearlong study led by UT Southwestern Medical Center psychiatrists
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
What happens when doctors cannot cure a disease? What is the best way to make patients comfortable and have the best quality of life possible in the time they have left? Researchers at the Norwegian University of Science and Technology (NTNU) have developed software that can be used with an iPad or other tablet to help record patient pain levels to help doctors in developing further treatment.
Air pollution has already been linked to a range of health problems. Now, a ground-breaking new study suggests pollution from traffic may put women at risk for another deadly disease.
› Verified 3 days ago
Promptmed Urgent Care Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2502 25th St, Columbus, IN 47201 Phone: 812-372-8883 Fax: 812-372-8964 | |
Columbus Regional Health Physicians, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2325 18th St, Suite 130, Columbus, IN 47201 Phone: 812-379-2020 | |
Centerstone Health Services, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 720 N Marr Rd Ste A, Columbus, IN 47201 Phone: 812-314-3400 Fax: 812-376-4875 | |
Columbus Regional Health Physicians, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2326 18th St, Suite 120, Columbus, IN 47201 Phone: 812-372-1570 | |
Columbus Regional Health Physicians, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2326 18th St, Suite 210, Columbus, IN 47201 Phone: 812-372-8426 | |
Ourhealth Physicians Group, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6125 Inwood Dr, Columbus, IN 47201 Phone: 866-434-3255 | |
Cummins Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 806 Jackson St, Columbus, IN 47201 Phone: 812-748-3412 Fax: 812-748-3413 |